These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34441032)

  • 21. Epistatic interactions between mutations of TACI (
    Ameratunga R; Koopmans W; Woon ST; Leung E; Lehnert K; Slade CA; Tempany JC; Enders A; Steele R; Browett P; Hodgkin PD; Bryant VL
    Clin Transl Immunology; 2017 Oct; 6(10):e159. PubMed ID: 29114388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TACI is mutant in common variable immunodeficiency and IgA deficiency.
    Castigli E; Wilson SA; Garibyan L; Rachid R; Bonilla F; Schneider L; Geha RS
    Nat Genet; 2005 Aug; 37(8):829-34. PubMed ID: 16007086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.
    Jabara HH; Lee JJ; Janssen E; Ullas S; Liadaki K; Garibyan L; Benson H; Sannikova T; Bram R; Hammarstrom L; Cruz AC; Siegel R; Manis J; Malley R; Geha RS
    J Allergy Clin Immunol; 2017 Apr; 139(4):1293-1301.e4. PubMed ID: 27609654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).
    Garibyan L; Lobito AA; Siegel RM; Call ME; Wucherpfennig KW; Geha RS
    J Clin Invest; 2007 Jun; 117(6):1550-7. PubMed ID: 17492055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.
    Salzer U; Bacchelli C; Buckridge S; Pan-Hammarström Q; Jennings S; Lougaris V; Bergbreiter A; Hagena T; Birmelin J; Plebani A; Webster AD; Peter HH; Suez D; Chapel H; McLean-Tooke A; Spickett GP; Anover-Sombke S; Ochs HD; Urschel S; Belohradsky BH; Ugrinovic S; Kumararatne DS; Lawrence TC; Holm AM; Franco JL; Schulze I; Schneider P; Gertz EM; Schäffer AA; Hammarström L; Thrasher AJ; Gaspar HB; Grimbacher B
    Blood; 2009 Feb; 113(9):1967-76. PubMed ID: 18981294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
    Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
    J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological characteristics and two novel mutations in TACI in a cohort of 28 pediatric patients with common variable immunodeficiency.
    Almejún MB; Sajaroff E; Galicchio M; Oleastro M; Bernasconi A; Zelazko M; Danielian S
    J Clin Immunol; 2012 Feb; 32(1):89-97. PubMed ID: 22076597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells.
    Smulski CR; Zhang L; Burek M; Teixidó Rubio A; Briem JS; Sica MP; Sevdali E; Vigolo M; Willen L; Odermatt P; Istanbullu D; Herr S; Cavallari M; Hess H; Rizzi M; Eibel H; Schneider P
    Cell Rep; 2022 Mar; 38(13):110583. PubMed ID: 35354034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TACI deficiency - a complex system out of balance.
    Salzer U; Grimbacher B
    Curr Opin Immunol; 2021 Aug; 71():81-88. PubMed ID: 34247095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiency.
    Berglund LJ; Jones GJ; Murali R; Fulcher DA
    J Allergy Clin Immunol; 2006 Apr; 117(4):870-7. PubMed ID: 16630947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common variable immunodeficiency: two mutations are better than one.
    La Cava A
    J Clin Invest; 2013 Oct; 123(10):4142-3. PubMed ID: 24051372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
    Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
    J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of TACI mutations: from hypogammaglobulinemia in infancy to autoimmunity in adulthood.
    Barroeta Seijas AB; Graziani S; Cancrini C; Finocchi A; Ferrari S; Miniero R; Conti F; Zuntini R; Chini L; Chiarello P; Bengala M; Rossi P; Moschese V; Di Matteo G
    Int J Immunopathol Pharmacol; 2012; 25(2):407-14. PubMed ID: 22697072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TACI mutations and disease susceptibility in patients with common variable immunodeficiency.
    Poodt AE; Driessen GJ; de Klein A; van Dongen JJ; van der Burg M; de Vries E
    Clin Exp Immunol; 2009 Apr; 156(1):35-9. PubMed ID: 19210517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of common variable immunodeficiency.
    Castigli E; Geha RS
    J Allergy Clin Immunol; 2006 Apr; 117(4):740-6; quiz 747. PubMed ID: 16630927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen.
    Tsuji S; Stein L; Kamada N; Nuñez G; Bram R; Vallance BA; Sousa AE; Platt JL; Cascalho M
    J Clin Invest; 2014 Nov; 124(11):4857-66. PubMed ID: 25271628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of TACI signaling on humoral immunity and autoimmune diseases.
    Zhang Y; Li J; Zhang YM; Zhang XM; Tao J
    J Immunol Res; 2015; 2015():247426. PubMed ID: 25866827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-omics analysis of naïve B cells of patients harboring the C104R mutation in TACI.
    Ramirez N; Posadas-Cantera S; Langer N; de Oteyza ACG; Proietti M; Keller B; Zhao F; Gernedl V; Pecoraro M; Eibel H; Warnatz K; Ballestar E; Geiger R; Bossen C; Grimbacher B
    Front Immunol; 2022; 13():938240. PubMed ID: 36072607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.
    Knight AK; Radigan L; Marron T; Langs A; Zhang L; Cunningham-Rundles C
    Clin Immunol; 2007 Aug; 124(2):182-9. PubMed ID: 17556024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome.
    Chinen J; Martinez-Gallo M; Gu W; Cols M; Cerutti A; Radigan L; Zhang L; Potocki L; Withers M; Lupski JR; Cunningham-Rundles C
    J Allergy Clin Immunol; 2011 Jun; 127(6):1579-86. PubMed ID: 21514638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.